Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2024)

Historic Long-Term Deferred Tax for CV Sciences (CVSI) over the last 6 years, with Q4 2024 value amounting to $13.7 million.

  • CV Sciences' Long-Term Deferred Tax fell 2027.88% to $13.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $13.7 million, marking a year-over-year decrease of 2027.88%. This contributed to the annual value of $13.7 million for FY2024, which is 2027.88% down from last year.
  • Per CV Sciences' latest filing, its Long-Term Deferred Tax stood at $13.7 million for Q4 2024, which was down 2027.88% from $17.1 million recorded in Q4 2023.
  • In the past 5 years, CV Sciences' Long-Term Deferred Tax ranged from a high of $17.9 million in Q4 2022 and a low of $13.7 million during Q4 2024
  • Its 3-year average for Long-Term Deferred Tax is $16.2 million, with a median of $17.1 million in 2023.
  • In the last 5 years, CV Sciences' Long-Term Deferred Tax plummeted by 427.65% in 2023 and then plummeted by 2027.88% in 2024.
  • Quarter analysis of 3 years shows CV Sciences' Long-Term Deferred Tax stood at $17.9 million in 2022, then decreased by 4.28% to $17.1 million in 2023, then dropped by 20.28% to $13.7 million in 2024.
  • Its last three reported values are $13.7 million in Q4 2024, $17.1 million for Q4 2023, and $17.9 million during Q4 2022.